The National Academies
Health and Medicine Division
Explore by Topic
Biomedical and Health Research
Children, Youth and Families
Food and Nutrition
Health Care Workforce
Health Services, Coverage, and Access
Military and Veterans Health
Quality and Patient Safety
Select Populations and Health Disparities
Substance Use and Mental Health
Displaying: 1 to 9 of 9 Meetings
Workshop on Potential Health Hazards Associated with Consumption of Caffeine in Food and Dietary Supplements
Date: August 5, 2013 - August 6, 2013 (8:30 AM Eastern)
The Institute of Medicine (IOM) will organize a 2-day public workshop to discuss potential health impacts stemming from the consumption of caffeine in dietary supplements and conventional foods, alone or in combination with other substances found in products commonly referred to as “energy products.”
Report Release: Ensuring Safe Foods and Medical Products Through Stronger Regulatory Systems Abroad
Date: April 4, 2012 (1:00 PM Eastern)
Public release of Ensuring Safe Foods and Medical Products Through Stronger Regulatory Systems Abroad
Meeting 2: Strengthening Core Elements of Regulatory Systems in Developing Countries
Date: July 27, 2011 - July 28, 2011 (9:00 AM Eastern)
The second full committee meeting of the Committee on Strengthening Core Elements of Regulatory Systems in Developing Countries.
Meeting 1: Strengthening Core Elements of Regualtory Systems in Developing Countries
Date: March 2, 2011 - March 3, 2011 (9:00 AM Eastern)
The first full committee meeting of the Committee on Strengthening Core Elements of Regulatory Systems in Developing Countries.
Biomarkers Discussion Forum
Date: June 21, 2010 - June 22, 2010 (9:00 AM Eastern)
Biomarkers Discussion Forum
Meeting 4:Qualification of Biomarkers and Surrogate Endpoints of Chronic Disease
Date: October 13, 2009 - October 14, 2009 (8:00 AM Eastern)
Meeting 3: Qualification of Biomarkers and Surrogate Endpoints of Chronic Disease
Date: July 30, 2009 - July 31, 2009 (8:30 AM Eastern)
During this closed meeting, the committee reviewed and deliberated over a draft report produced by committee input. The committee suggested changes and agreed to review the revised draft prior to Meeting 4. The committee also discussed future disemmination efforts.
Meeting 2: Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease
Date: April 6, 2009 (8:00 AM Eastern)
This workshop featured presentations concerning current issues in biomarker qualification, as well as existing frameworks for qualification. In addition, the workshop explored decision analysis tools, specific case studies, and contexts of use for biomarker qualification.
Meeting 1: Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease
Date: January 12, 2009 (8:30 AM Eastern)
The public was invited to attend the two open sessions of this meeting that focused on the current methodologies used for biomarker qualification within the FDA and the various issues that the committee must consider when creating recommendations to the FDA.